Results for "**Fatigue**"
Conditions Encyclopedia Entry 1775524085
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MMs) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are characterized by progressive muscle weakness, wasting, and other systemic symptoms. MMs are caused by mutations in the mitochondrial DNA, which codes for essential proteins involved in energy production. The symptoms of MMs can vary depending on the specific mutation and the affected tissues, but they often include muscle weakness, fatigue, and exercise intolerance. Mitochondrial Myopathies are a complex and heterogeneous group of disorders, and their diagnosis can be challenging. The symptoms of MMs can be similar to those of other neuromuscular disorders, such as muscular dystrophy or peripheral neuropathy. Therefore, a comprehensive diagnostic workup, including genetic testing, muscle biopsy, and other investigations, is essential to confirm the diagnosis. ## History/Background The first reported case of a mitochondrial myopathy was in 1962, when a British neurologist, **David E. Cooper**, described a patient with a rare disorder characterized by progressive muscle weakness and wasting. However, it was not until the 1980s that the genetic basis of MMs was understood. The discovery of the mitochondrial DNA and the identification of mutations in the mitochondrial genome revolutionized the field of mitochondrial medicine. ## Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which codes for essential proteins involved in energy production. The most common mutations associated with MMs are in the **mtDNA**, which is responsible for encoding the **NADH dehydrogenase** subunits. Other mutations can affect the **cytochrome c oxidase** or the **ATP synthase** subunits. The symptoms of MMs can vary depending on the specific mutation and the affected tissues. Muscle weakness and wasting are common symptoms, but other systemic symptoms can include: * **Fatigue**: a persistent feeling of tiredness or exhaustion * **Exercise intolerance**: difficulty performing physical activities due to muscle weakness or fatigue * **Muscle pain**: pain or cramping in the muscles * **Neurological symptoms**: numbness, tingling, or weakness in the limbs * **Visual disturbances**: blurred vision, double vision, or loss of vision ## Significance Mitochondrial Myopathies are a significant public health concern due to their rarity and the complexity of their diagnosis. The symptoms of MMs can be debilitating and affect the quality of life of affected individuals. However, with advances in genetic testing and molecular diagnosis, it is now possible to identify the underlying cause of MMs and provide targeted treatment. The study of MMs has also led to a greater understanding of the role of mitochondria in human health and disease. Mitochondria are essential for energy production in cells, and their dysfunction can lead to a range of disorders, including MMs. The study of MMs has also highlighted the importance of **epigenetics**, the study of gene expression and its regulation, in the development of complex diseases. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorder - **Date:** 1962 (first reported case) - **Location:** Worldwide - **Known For:** Progressive muscle weakness, wasting, and other systemic symptoms TAGS: **Mitochondrial Myopathies**, **Mitochondrial DNA**, **NADH dehydrogenase**, **Cytochrome c oxidase**, **ATP synthase**, **Exercise intolerance**, **Fatigue**, **Muscle pain**, **Neurological symptoms**, **Visual disturbances**
Health & MedicineConditions Encyclopedia Entry 1777798821
** This article discusses **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells, leading to muscle weakness and other systemic symptoms. ## Overview Mitochondrial Myopathies (MMs) are a group of rare genetic disorders caused by mutations in the mitochondrial DNA (mtDNA). These mutations affect the mitochondria's ability to produce energy, leading to a range of symptoms, including muscle weakness, fatigue, and other systemic problems. MMs are often inherited in an autosomal dominant pattern, meaning a single copy of the mutated gene is enough to cause the condition. The symptoms of MMs can vary widely depending on the specific mutation and the individual affected. MMs are characterized by a range of symptoms, including muscle weakness, particularly in the muscles of the face, arms, and legs. Other symptoms may include fatigue, shortness of breath, and swallowing difficulties. Some individuals with MMs may also experience seizures, hearing loss, and vision problems. In severe cases, MMs can lead to life-threatening complications, such as cardiac arrest and respiratory failure. Diagnosing MMs can be challenging, as the symptoms are often nonspecific and can be similar to those of other conditions. A diagnosis is typically made through a combination of genetic testing, muscle biopsy, and other diagnostic tests. Treatment for MMs is often focused on managing symptoms and improving quality of life, rather than curing the underlying condition. ## History/Background The first descriptions of MMs date back to the 1960s, when researchers identified a group of patients with muscle weakness and other systemic symptoms. Over the years, further research has led to a greater understanding of the genetic basis of MMs and the development of new diagnostic and treatment options. In the 1980s, researchers discovered that MMs were caused by mutations in the mtDNA. This breakthrough led to the development of genetic testing for MMs, which has become an essential tool in diagnosis. In the 1990s, researchers identified several key genes associated with MMs, including the **MT-ND1** gene, which is involved in the production of energy in the mitochondria. ## Key Information * **Prevalence:** MMs are rare, affecting approximately 1 in 5,000 to 1 in 10,000 people worldwide. * **Genetics:** MMs are caused by mutations in the mtDNA, which is inherited from one's parents. * **Symptoms:** Muscle weakness, fatigue, shortness of breath, swallowing difficulties, seizures, hearing loss, and vision problems. * **Diagnostic tests:** Genetic testing, muscle biopsy, and other diagnostic tests. * **Treatment:** Symptom management, including physical therapy, speech therapy, and medication to manage symptoms. ## Significance MMs are significant because they highlight the importance of mitochondrial function in maintaining overall health. The symptoms of MMs can have a profound impact on an individual's quality of life, making it essential to develop effective treatments and management strategies. Research into MMs has also led to a greater understanding of the genetic basis of other conditions, such as Alzheimer's disease and Parkinson's disease. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first descriptions) - **Location:** Worldwide - **Known For:** Rare genetic disorder affecting mitochondrial function TAGS: **Mitochondrial Myopathies**, **Genetic disorder**, **Mitochondrial function**, **Muscle weakness**, **Fatigue**, **Symptom management**, **Genetic testing**, **Rare disease**
Health & MedicineConditions Encyclopedia Entry 1780582508
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial myopathies are a category of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is responsible for producing energy for the cell. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of mitochondrial myopathies can vary widely, but often include muscle weakness, fatigue, and exercise intolerance. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is enough to cause the disorder, and the disorder is passed down from the mother. The diagnosis of mitochondrial myopathies is often challenging, as the symptoms can be similar to those of other conditions, and there is no single test that can confirm the diagnosis. A combination of genetic testing, muscle biopsy, and other diagnostic tests may be used to confirm the diagnosis. ## History/Background Mitochondrial myopathies were first described in the 1960s, but it wasn't until the 1980s that the genetic basis of these disorders was understood. In 1988, a team of researchers led by Dr. Douglas C. Wallace discovered the first mitochondrial DNA mutation associated with a mitochondrial myopathy. Since then, numerous other mutations have been identified, and the genetic basis of these disorders has been extensively studied. ## Key Information Mitochondrial myopathies are caused by mutations in the mitochondrial DNA, which can lead to a range of symptoms, including: * Muscle weakness and wasting * Fatigue and exercise intolerance * Numbness and tingling in the hands and feet * Difficulty swallowing and speaking * Vision and hearing loss * Cognitive impairment and dementia There are several types of mitochondrial myopathies, including: * **Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)**: a condition characterized by muscle weakness, seizures, and stroke-like episodes. * **Myoclonic epilepsy with ragged-red fibers (MERRF)**: a condition characterized by muscle weakness, seizures, and ragged-red fibers in muscle biopsies. * **Kearns-Sayre syndrome**: a condition characterized by muscle weakness, heart problems, and vision loss. ## Significance Mitochondrial myopathies are a significant public health concern, as they can affect individuals of any age, sex, or ethnicity. These disorders can have a profound impact on an individual's quality of life, causing significant disability and mortality. While there is currently no cure for mitochondrial myopathies, various treatments are available to manage the symptoms and slow disease progression. **Research and treatment advances** have improved the diagnosis and management of mitochondrial myopathies, but more research is needed to understand the underlying causes of these disorders and to develop effective treatments. Support groups and advocacy organizations, such as the **Mitochondrial Medicine Society**, play a crucial role in raising awareness and promoting research into these disorders. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** 1960s (first described) - **Location:** Global - **Known For:** Rare genetic disorders affecting the mitochondria TAGS: **Mitochondrial myopathies**, **Genetic disorders**, **Mitochondrial DNA**, **Muscle weakness**, **Fatigue**, **Exercise intolerance**, **Rare diseases**, **Genetic testing**, **Muscle biopsy**, **Mitochondrial medicine**, **Support groups**, **Advocacy organizations**
Health & MedicineConditions Encyclopedia Entry 1778155326
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders caused by mutations in the mitochondrial DNA (mtDNA) or nuclear DNA (nDNA). These conditions affect the mitochondria, which are responsible for producing energy for the body's cells. Mitochondrial myopathies can cause a range of symptoms, including muscle weakness, fatigue, and pain. The disorders are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is enough to cause the condition. Mitochondrial myopathies can be classified into several subtypes, including Kearns-Sayre syndrome (KSS), Myoclonic Epilepsy with Ragged-Red Fibers (MERRF), and Chronic Progressive External Ophthalmoplegia (CPEO). Each subtype has distinct characteristics and symptoms, but all share the underlying mitochondrial dysfunction. ## History/Background The first reported case of mitochondrial myopathy was in 1957 by Dr. John Walton, a British neurologist. However, it wasn't until the 1970s and 1980s that the condition gained more attention, with the discovery of the mitochondrial DNA and the development of techniques to study it. In 1981, the first mitochondrial myopathy was described by Dr. John Holt, an American neurologist. Since then, numerous studies have been conducted to understand the genetic and molecular mechanisms underlying mitochondrial myopathies. ## Key Information Mitochondrial myopathies are caused by mutations in the mitochondrial DNA or nuclear DNA, which affect the production of energy for the body's cells. The symptoms of MM can vary widely, but common features include: - Muscle weakness and wasting - Fatigue and exercise intolerance - Pain and cramping - Difficulty swallowing (dysphagia) - Vision problems (including blindness) - Hearing loss - Cognitive impairment - Seizures The diagnosis of MM is often based on a combination of clinical evaluation, genetic testing, and muscle biopsy. Genetic testing can identify the specific mutation responsible for the condition, while muscle biopsy can help confirm the diagnosis and assess the extent of mitochondrial damage. ## Significance Mitochondrial myopathies are rare conditions, affecting approximately 1 in 5,000 to 1 in 10,000 people worldwide. However, they have significant implications for patients and their families. The conditions can cause significant morbidity and mortality, with some patients experiencing rapid progression of symptoms. Research into mitochondrial myopathies has led to a greater understanding of the importance of mitochondrial function in human health and disease. This knowledge has implications for the development of treatments for a range of conditions, including neurodegenerative diseases and cancer. ## INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** 1957 (first reported case) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting mitochondrial function ## TAGS: **Mitochondrial Myopathies**, **Genetic Disorders**, **Muscle Weakness**, **Fatigue**, **Pain**, **Mitochondrial DNA**, **Nuclear DNA**, **Rare Conditions**, **Neurodegenerative Diseases**, **Cancer**, **Genetic Testing**, **Muscle Biopsy**